44P Real-world overall survival in second-line maintenance niraparib monotherapy vs active surveillance in patients with recurrent ovarian cancer
| Autor: | Moore, K.N., Perhanidis, J., Kalilani, L., Zimmerman, N., Golembesky, A., Coleman, R.L. |
|---|---|
| Zdroj: | In ESMO Open February 2023 8(1) Supplement 1 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|